Envestnet Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,016
| Closed | -$104K | – | 4432 |
|
|
2024
Q4 | $104K | Sell |
19,016
-23,677
| -55% | -$129K | ﹤0.01% | 4206 |
|
|
2024
Q3 | $355K | Sell |
42,693
-7,540
| -15% | -$62.7K | ﹤0.01% | 3724 |
|
|
2024
Q2 | $360K | Sell |
50,233
-2,458
| -5% | -$17.6K | ﹤0.01% | 3626 |
|
|
2024
Q1 | $457K | Buy |
52,691
+17,948
| +52% | +$156K | ﹤0.01% | 3498 |
|
|
2023
Q4 | $228K | Sell |
34,743
-42,612
| -55% | -$279K | ﹤0.01% | 3763 |
|
|
2023
Q3 | $774K | Buy |
77,355
+10,193
| +15% | +$102K | ﹤0.01% | 2999 |
|
|
2023
Q2 | $835K | Sell |
67,162
-77,494
| -54% | -$963K | ﹤0.01% | 2874 |
|
|
2023
Q1 | $658K | Buy |
144,656
+116,329
| +411% | +$530K | ﹤0.01% | 2965 |
|
|
2022
Q4 | $405K | Sell |
28,327
-6,002
| -17% | -$85.9K | ﹤0.01% | 3221 |
|
|
2022
Q3 | $876K | Sell |
34,329
-14,526
| -30% | -$371K | ﹤0.01% | 2677 |
|
|
2022
Q2 | $1.39M | Buy |
48,855
+22,472
| +85% | +$638K | ﹤0.01% | 2350 |
|
|
2022
Q1 | $931K | Buy |
26,383
+1,107
| +4% | +$39.1K | ﹤0.01% | 2719 |
|
|
2021
Q4 | $1.06M | Buy |
25,276
+10,208
| +68% | +$428K | ﹤0.01% | 2596 |
|
|
2021
Q3 | $740K | Buy |
15,068
+1,177
| +8% | +$57.8K | ﹤0.01% | 2734 |
|
|
2021
Q2 | $580K | Buy |
13,891
+4,519
| +48% | +$189K | ﹤0.01% | 2884 |
|
|
2021
Q1 | $334K | Buy |
9,372
+1,111
| +13% | +$39.6K | ﹤0.01% | 3078 |
|
|
2020
Q4 | $232K | Buy |
+8,261
| New | +$232K | ﹤0.01% | 3057 |
|